Pelvic Exenteration for Cervical Cancer that is Persistent or Recurrent after Radiotherapy or Chemoradiation. Institutional Experience of 51 Years

Abstract

Objective: To investigate the morbidity, mortality and results of treatment with pelvic exenteration (PE) in patients with cervical cancer (CC) that was persistent or recurrent following Radiotherapy (RT) or Chemoradiation (CCRT), through 51 years of institutional experience.